Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gerard M. Jensen. (2017) The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®). Journal of Liposome Research 27:3, pages 173-179.
Read now
Read now
J. P. Adler-Moore, R. T. Proffitt, J. A. Olson & G. M. Jensen. (2017) Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens. Journal of Liposome Research 27:3, pages 195-209.
Read now
Read now
Qamar Zia, Aijaz Ahmed Khan, Zubair Swaleha & Mohammad Owais. (2015) Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans. International Journal of Nanomedicine 10, pages 1769-1790.
Read now
Read now
Angela S Loo, Saif A Muhsin & Thomas J Walsh. (2013) Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
. Expert Opinion on Drug Safety 12:6, pages 881-895.
Read now
Read now
J.-U. Junghanns, I. Buttle, R.H. Müller, I.B. Araújo, A.K.A. Silva, E.S.T. Egito & B.P.G.L. Damasceno. (2007) SolEmuls® Technology: A Way to Overcome the Drawback of Parenteral Administration of Insoluble Drugs. Pharmaceutical Development and Technology 12:5, pages 437-445.
Read now
Read now
Gerard M. Jensen & Tarquinus H. Bunch. (2007) Conventional Liposome Performance and Evaluation: Lessons from the Development of Vescan. Journal of Liposome Research 17:3-4, pages 121-137.
Read now
Read now
Theodore F. Taraschi & Joseph M. Beggs. (2000) Letters. Journal of Liposome Research 10:1, pages 96-98.
Read now
Read now
Articles from other publishers (28)
R J Brüggemann, G M Jensen & C Lass-Flörl. (2022) Liposomal amphotericin B—the past. Journal of Antimicrobial Chemotherapy 77:Supplement_2, pages ii3-ii10.
Crossref
Crossref
Richard Marx, Jaeweon Lee, Yuri Svirkin, Seongkyu Yoon, Nelson Landrau, Md Abul Kaisar, Bin Qin, Jin H. Park, Khondoker Alam, Darby Kozak, Yan Wang, Xiaoming Xu, Jiwen Zheng & Benjamin Rivnay. (2022) Physicochemical surrogates for in vitro toxicity assessment of liposomal amphotericin B. International Journal of Pharmaceutics 628, pages 122273.
Crossref
Crossref
Yuri Svirkin, Jaeweon Lee, Richard Marx, Seongkyu Yoon, Nelson Landrau, Md Abul Kaisar, Bin Qin, Jin H. Park, Khondoker Alam, Darby Kozak, Yan Wang, Xiaoming Xu, Jiwen Zheng & Benjamin Rivnay. (2022) Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity. Asian Journal of Pharmaceutical Sciences 17:4, pages 544-556.
Crossref
Crossref
Jayesh A. Kulkarni, Sam Chen & Yuen Yi C. Tam. (2021) Scalable Production of Lipid Nanoparticles Containing Amphotericin B. Langmuir 37:24, pages 7312-7319.
Crossref
Crossref
Elsa R. Arias, Vivian Angarita-Villamizar, Yolima Baena, Claudia Parra-Giraldo & Leon D. Perez. (2021) Phospholipid-Conjugated PEG-b-PCL Copolymers as Precursors of Micellar Vehicles for Amphotericin B. Polymers 13:11, pages 1747.
Crossref
Crossref
Angie V. Angarita-Villamizar, Elsa R. Arias, Ivonne L. Diaz & Leon D. Perez. (2021) Amphiphilic copolymers modified with oleic acid and cholesterol by combining ring opening polymerization and click chemistry with improved amphotericin B loading capacity. Journal of Polymer Research 28:1.
Crossref
Crossref
Yayuan Liu, Zihan Mei, Ling Mei, Jie Tang, Wenmin Yuan, Santhanakrishnan Srinivasan, Rose Ackermann & Anna S. Schwendeman. (2020) Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products. European Journal of Pharmaceutics and Biopharmaceutics 157, pages 241-249.
Crossref
Crossref
Huolong Liu, Benjamin Rivnay, Ken Avery, Ja Hye Myung, Darby Kozak, Nelson Landrau, Alex Nivorozhkin, Muhammad Ashraf & Seongkyu Yoon. (2020) Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach. International Journal of Pharmaceutics 585, pages 119473.
Crossref
Crossref
Yeimy J. Rodriguez, Luis F. Quejada, Jean C. Villamil, Yolima Baena, Claudia M. Parra-Giraldo & Leon D. Perez. (2020) Development of Amphotericin B Micellar Formulations Based on Copolymers of Poly(ethylene glycol) and Poly(ε-caprolactone) Conjugated with Retinol. Pharmaceutics 12:3, pages 196.
Crossref
Crossref
Kaushik Thanki, Tushar Date & Sanyog Jain. (2019) Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach. Molecular Pharmaceutics 16:11, pages 4519-4529.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Benjamin Rivnay, Joseph Wakim, Ken Avery, Peter Petrochenko, Ja Hye Myung, Darby Kozak, Seongkyu Yoon, Nelson Landrau & Alex Nivorozhkin. (2019) Critical process parameters in manufacturing of liposomal formulations of amphotericin B. International Journal of Pharmaceutics 565, pages 447-457.
Crossref
Crossref
Louise Walker, Prashant Sood, Megan D. Lenardon, Gillian Milne, Jon Olson, Gerard Jensen, Julie Wolf, Arturo Casadevall, Jill Adler-Moore & Neil A. R. Gow. (2018) The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles. mBio 9:1.
Crossref
Crossref
Maryam Iman, Zhaohua Huang, Seyedeh Hoda Alavizadeh, Francis C. SzokaJr.Jr. & Mahmoud R. Jaafari. (2017)
Biodistribution and
In Vivo
Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-
sn
-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B
. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
Jill P Adler-Moore, Jean-Pierre Gangneux & Peter G Pappas. (2016) Comparison between liposomal formulations of amphotericin B. Medical Mycology 54:3, pages 223-231.
Crossref
Crossref
J. A. Olson, J. A. Schwartz, D. Hahka, N. Nguyen, T. Bunch, G. M. Jensen & J. P. Adler-Moore. (2014) Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice. Medical Mycology 53:2, pages 107-118.
Crossref
Crossref
Maryam Iman, Zhaohua Huang, Francis C. SzokaJr.Jr. & Mahmoud R. Jaafari. (2011) Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin B. International Journal of Pharmaceutics 408:1-2, pages 163-172.
Crossref
Crossref
Jodi M. Lestner, Susan J. Howard, Joanne Goodwin, Lea Gregson, Jayesh Majithiya, Thomas J. Walsh, Gerard M. Jensen & William W. Hope. (2010)
Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an
In Vitro
Model of Invasive Pulmonary Aspergillosis
. Antimicrobial Agents and Chemotherapy 54:8, pages 3432-3441.
Crossref
Crossref
J.P. Adler-Moore & R.T. Proffitt. (2008) Amphotericin B lipid preparations: what are the differences?. Clinical Microbiology and Infection 14, pages 25-36.
Crossref
Crossref
Jon A. Olson, Jill P. Adler-Moore, Gerard M. Jensen, Julie Schwartz, M. Cecilia Dignani & Richard T. Proffitt. (2008) Comparison of the Physicochemical, Antifungal, and Toxic Properties of Two Liposomal Amphotericin B Products. Antimicrobial Agents and Chemotherapy 52:1, pages 259-268.
Crossref
Crossref
G. M. Jensen, C. S. Ashvar, S. W. Bunte, C. D. Barzak, T. H. Bunch, R. L. Fahrner, N. Hu, J. Kennavane, H. Pham, C. Skenes & S. Yang. (2007) A liposomal dispersion formulation of propofol: formulation, pharmacokinetics, stability, and identification of an oxidative degradant. Theoretical Chemistry Accounts 119:1-3, pages 291-296.
Crossref
Crossref
Gerard Jensen, Tarquinus Bunch, Ning Hu & Crispin Eley. 2006. Liposome Technology, Volume I. Liposome Technology, Volume I
297
310
.
Jon A. Olson, Jill P. Adler-Moore, Julie Schwartz, Gerard M. Jensen & Richard T. Proffitt. (2006) Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model. Antimicrobial Agents and Chemotherapy 50:6, pages 2122-2131.
Crossref
Crossref
Richard Proffitt & Jill Adler-Moore. 2005. Injectable Dispersed Systems. Injectable Dispersed Systems
481
525
.
Ivonete Batista Araújo, C. Ramon N. Brito, Isabel A. Urbano, Victor A. Dominici, Miguel A. Silva Filho, Walteçá L. L. Silveira, Bolívar P. G. L. Damasceno, Aldo Cunha Medeiros & E. Sócrates T. Egito. (2005) Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures. Acta Cirurgica Brasileira 20:suppl 1, pages 129-133.
Crossref
Crossref
Lloyd W. Turtinen, David N. Prall, Lindsay A. Bremer, Rachel E. Nauss & Scott C. Hartsel. (2004) Antibody Array-Generated Profiles of Cytokine Release from THP-1 Leukemic Monocytes Exposed to Different Amphotericin B Formulations. Antimicrobial Agents and Chemotherapy 48:2, pages 396-403.
Crossref
Crossref
J. P. Adler-Moore & R. T. Proffitt. 2004. Human Fungal Pathogens. Human Fungal Pathogens
339
362
.
E.Sócrates T. Egito, Ivonete B. Araújo, Bolivar P.G.L. Damasceno & James C. Price. (2002) Amphotericin B/Emulsion Admixture Interactions: An Approach Concerning the Reduction of Amphotericin B Toxicity. Journal of Pharmaceutical Sciences 91:11, pages 2354-2366.
Crossref
Crossref